The stock might be down substantially over the past three years, but it isn't out of the picture yet. Teladoc Health is a ...

Biotechnology company Moderna (NASDAQ:MRNA) in Q1 CY2025, with sales falling 35.3% year on year to $108 million. The ...

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

The anti-mRNA sentiment — coupled with the sweeping shake-up of science funding across the United States — has sparked fears ...

Morabaha Marina Financing Co. (MRNA) said it will not be able to release its preliminary financial results for the ...

Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...

RNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines.

A genome-wide association study in Sweden identified rare genetic variants near the SCAF11 and LRRC4C genes that may be ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

K nowing the location of a gene within intact tissue or a single cell allows scientists to unlock unknown cellular functions.